Recombinant Human TSH alpha/beta Heterodimer Protein (HEK293)，His

Thyroid-stimulating hormone (TSH) is a vital glycoprotein hormone composed of two subunits, alpha and beta, which together form a functional heterodimer. The alpha subunit is shared among several glycoprotein hormones, including luteinizing hormone (LH), follicle-stimulating hormone (FSH), and human chorionic gonadotropin (hCG), while the beta subunit is unique to TSH and is responsible for its specificity in stimulating the thyroid gland. The recombinant production of TSH alpha/beta heterodimeric proteins has gained significant interest due to its potential applications in both basic and clinical research, particularly in understanding thyroid function and disorders such as hypothyroidism and hyperthyroidism. Traditional methods of obtaining TSH are often limited by ethical concerns and low yield, making recombinant proteins an attractive alternative. Researchers are exploring various expression systems, including yeast, bacterial, and mammalian cell lines, to produce biologically active TSH heterodimers. These studies aim to elucidate the structure-function relationships of TSH and how it interacts with its receptor, TSR, advancing our knowledge of thyroid physiology and providing insights for therapeutic interventions. Furthermore, the availability of recombinant TSH can facilitate the development of new diagnostic tools and treatments for thyroid-related diseases, thereby contributing to improved patient care. The ongoing research into recombinant TSH alpha/beta heterodimers underscores the critical intersection of biotechnology and endocrinology, highlighting the importance of understanding hormonal signaling pathways for innovative medical solutions.